Europe PMCopen access
GLP-1 receptor agonists in stroke prevention: a narrative review on emerging therapeutic frontiers
Type 2 diabetes mellitus, Stroke, neuroprotection, Cerebrovascular Circulation, Glucagon-like Peptide 1 Receptor Agonists
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 123336
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.